Canada Pension Plan Investment Board Has $5.74 Million Position in Teleflex Incorporated $TFX

Key Points

• The Canada Pension Plan Investment Board increased its stake in Teleflex Inc. by 86.1% during the first quarter, now owning 41,500 shares worth approximately $5.7 million.
• Teleflex recently disclosed a quarterly dividend of $0.34 per share, with an annual yield of 1.1%, set to be paid on September 15th.
• In the most recent fiscal quarter, Teleflex reported an earnings per share (EPS) of $3.73, surpassing analysts' expectations of $3.36, along with revenue of $780.9 million.

Canada Pension Plan Investment Board boosted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 86.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,500 shares of the medical technology company's stock after purchasing an additional 19,200 shares during the quarter. Canada Pension Plan Investment Board owned about 0.09% of Teleflex worth $5,735,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Banque Cantonale Vaudoise bought a new stake in shares of Teleflex during the 1st quarter valued at about $27,000. MassMutual Private Wealth & Trust FSB grew its stake in Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after purchasing an additional 100 shares during the period. Costello Asset Management INC bought a new stake in Teleflex in the first quarter worth $28,000. Brooklyn Investment Group boosted its holdings in Teleflex by 258.6% in the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock worth $29,000 after acquiring an additional 150 shares in the last quarter. Finally, Whipplewood Advisors LLC boosted its holdings in Teleflex by 7,700.0% in the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after acquiring an additional 231 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Insider Transactions at Teleflex

In other Teleflex news, Director Stuart A. Randle bought 1,000 shares of Teleflex stock in a transaction on Tuesday, August 5th. The shares were acquired at an average price of $115.86 per share, for a total transaction of $115,860.00. Following the completion of the purchase, the director directly owned 7,547 shares in the company, valued at approximately $874,395.42. This trade represents a 15.27% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Liam Kelly purchased 1,500 shares of the firm's stock in a transaction on Tuesday, August 5th. The stock was acquired at an average price of $115.07 per share, with a total value of $172,605.00. Following the completion of the purchase, the chief executive officer owned 45,267 shares of the company's stock, valued at $5,208,873.69. The trade was a 3.43% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 5,500 shares of company stock valued at $633,590. 1.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on TFX shares. Mizuho increased their target price on Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a report on Friday, August 1st. Wall Street Zen upgraded Teleflex from a "buy" rating to a "strong-buy" rating in a research note on Sunday. Royal Bank Of Canada boosted their price target on Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research note on Friday, August 1st. Finally, Wells Fargo & Company reduced their price target on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $141.57.

Teleflex Stock Performance

TFX traded down $0.83 on Monday, hitting $129.87. 462,534 shares of the company's stock were exchanged, compared to its average volume of 777,458. The stock has a fifty day moving average of $119.91 and a two-hundred day moving average of $127.34. Teleflex Incorporated has a twelve month low of $108.90 and a twelve month high of $249.90. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. The firm has a market cap of $5.74 billion, a PE ratio of 30.55, a P/E/G ratio of 1.82 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating analysts' consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. During the same quarter last year, the firm earned $3.42 EPS. Teleflex's revenue for the quarter was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, August 15th. Teleflex's dividend payout ratio is 32.00%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.